Landi Maria Teresa, Chatterjee Nilanjan, Yu Kai, Goldin Lynn R, Goldstein Alisa M, Rotunno Melissa, Mirabello Lisa, Jacobs Kevin, Wheeler William, Yeager Meredith, Bergen Andrew W, Li Qizhai, Consonni Dario, Pesatori Angela C, Wacholder Sholom, Thun Michael, Diver Ryan, Oken Martin, Virtamo Jarmo, Albanes Demetrius, Wang Zhaoming, Burdette Laurie, Doheny Kimberly F, Pugh Elizabeth W, Laurie Cathy, Brennan Paul, Hung Rayjean, Gaborieau Valerie, McKay James D, Lathrop Mark, McLaughlin John, Wang Ying, Tsao Ming-Sound, Spitz Margaret R, Wang Yufei, Krokan Hans, Vatten Lars, Skorpen Frank, Arnesen Egil, Benhamou Simone, Bouchard Christine, Metspalu Andres, Metsapalu Andres, Vooder Tonu, Nelis Mari, Välk Kristian, Field John K, Chen Chu, Goodman Gary, Sulem Patrick, Thorleifsson Gudmar, Rafnar Thorunn, Eisen Timothy, Sauter Wiebke, Rosenberger Albert, Bickeböller Heike, Risch Angela, Chang-Claude Jenny, Wichmann H Erich, Stefansson Kari, Houlston Richard, Amos Christopher I, Fraumeni Joseph F, Savage Sharon A, Bertazzi Pier Alberto, Tucker Margaret A, Chanock Stephen, Caporaso Neil E
Division of Cancer Epidemiology, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA.
Am J Hum Genet. 2009 Nov;85(5):679-91. doi: 10.1016/j.ajhg.2009.09.012. Epub 2009 Oct 15.
Three genetic loci for lung cancer risk have been identified by genome-wide association studies (GWAS), but inherited susceptibility to specific histologic types of lung cancer is not well established. We conducted a GWAS of lung cancer and its major histologic types, genotyping 515,922 single-nucleotide polymorphisms (SNPs) in 5739 lung cancer cases and 5848 controls from one population-based case-control study and three cohort studies. Results were combined with summary data from ten additional studies, for a total of 13,300 cases and 19,666 controls of European descent. Four studies also provided histology data for replication, resulting in 3333 adenocarcinomas (AD), 2589 squamous cell carcinomas (SQ), and 1418 small cell carcinomas (SC). In analyses by histology, rs2736100 (TERT), on chromosome 5p15.33, was associated with risk of adenocarcinoma (odds ratio [OR]=1.23, 95% confidence interval [CI]=1.13-1.33, p=3.02x10(-7)), but not with other histologic types (OR=1.01, p=0.84 and OR=1.00, p=0.93 for SQ and SC, respectively). This finding was confirmed in each replication study and overall meta-analysis (OR=1.24, 95% CI=1.17-1.31, p=3.74x10(-14) for AD; OR=0.99, p=0.69 and OR=0.97, p=0.48 for SQ and SC, respectively). Other previously reported association signals on 15q25 and 6p21 were also refined, but no additional loci reached genome-wide significance. In conclusion, a lung cancer GWAS identified a distinct hereditary contribution to adenocarcinoma.
全基因组关联研究(GWAS)已鉴定出三个肺癌风险的基因位点,但肺癌特定组织学类型的遗传易感性尚未完全明确。我们开展了一项关于肺癌及其主要组织学类型的GWAS,在一项基于人群的病例对照研究和三项队列研究中的5739例肺癌病例和5848例对照中,对515,922个单核苷酸多态性(SNP)进行了基因分型。研究结果与另外十项研究的汇总数据相结合,共有13,300例病例和19,666例欧洲血统对照。四项研究还提供了组织学数据用于重复验证,产生了3333例腺癌(AD)、2589例鳞状细胞癌(SQ)和1418例小细胞癌(SC)。在按组织学进行的分析中,位于5号染色体p15.33的rs2736100(TERT)与腺癌风险相关(优势比[OR]=1.23,95%置信区间[CI]=1.13 - 1.33,p = 3.02×10⁻⁷),但与其他组织学类型无关(SQ和SC的OR分别为1.01,p = 0.84和OR = 1.00,p = 0.93)。这一发现在每项重复研究和总体荟萃分析中均得到证实(AD的OR = 1.24,95% CI = 1.17 - 1.31,p = 3.74×10⁻¹⁴;SQ和SC的OR分别为0.99,p = 0.69和OR = 0.97,p = 0.48)。其他先前报道的位于15q25和6p21的关联信号也得到了细化,但没有其他位点达到全基因组显著性。总之,一项肺癌GWAS确定了腺癌存在独特的遗传贡献。